These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 380618)

  • 1. Anti-tumour activity of ICI 118630, a new potent luteinizing hormone-releasing hormone agonist.
    Nicholson RI; Maynard PV
    Br J Cancer; 1979 Mar; 39(3):268-73. PubMed ID: 380618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of a new analogue of luteinizing hormone releasing hormone, ICI 118630, on the growth of rat mammary tumours [proceedings].
    Nicholson RI; Finney EJ; Maynard PV
    J Endocrinol; 1978 Nov; 79(2):51P-52P. PubMed ID: 366064
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone-releasing hormone antagonist SB-75.
    Szende B; Srkalovic G; Groot K; Lapis K; Schally AV
    J Natl Cancer Inst; 1990 Mar; 82(6):513-7. PubMed ID: 2156080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of rat mammary tumors by a potent luteinizing hormone-releasing hormone analogue (leuprolide) administered vaginally.
    Okada H; Sakura Y; Kawaji H; Yashiki T; Mima H
    Cancer Res; 1983 Apr; 43(4):1869-74. PubMed ID: 6403230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of experimental DMBA induced mammary carcinoma with Cetrorelix (SB-75): a potent antagonist of luteinizing hormone-releasing hormone.
    Reissmann T; Hilgard P; Harleman JH; Engel J; Comaru-Schally AM; Schally AV
    J Cancer Res Clin Oncol; 1992; 118(1):44-9. PubMed ID: 1530849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mammary tumor growth in rats and mice by administration of agonistic and antagonistic analogs of luteinizing hormone-releasing hormone.
    Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1983 Mar; 80(5):1459-62. PubMed ID: 6219395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of nitrosamine-induced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonists.
    Szende B; Srkalovic G; Groot K; Lapis K; Schally AV
    Cancer Res; 1990 Jun; 50(12):3716-21. PubMed ID: 2160323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of rat mammary tumors effected by a gonadoliberin analog.
    DeSombre ER; Johnson ES; White WF
    Cancer Res; 1976 Oct; 36(10):3830-3. PubMed ID: 782692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the luteinizing-hormone-releasing hormone (LHRH) antagonist ramorelix (hoe013) and the LHRH agonist buserelin on dimethylbenz[]anthracene-induced mammary carcinoma: studies with slow-release formulations.
    Stoeckemann K; Sandow J
    J Cancer Res Clin Oncol; 1993; 119(8):457-62. PubMed ID: 8509436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The measurement of tamoxifen and metabolites in the rat and relationship to the response of DMBA-induced mammary tumours.
    Daniel CP; Gaskell SJ; Nicholson RI
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):137-43. PubMed ID: 6420159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Schally AV; Redding TW
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine and antitumor effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumors.
    Bakker GH; Setyono-Han B; Portengen H; De Jong FH; Foekens JA; Klijn JG
    Endocrinology; 1989 Sep; 125(3):1593-8. PubMed ID: 2527151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations of droloxifene and other hormone manipulations on N-nitrosomethylurea-induced rat mammary tumours. 1. Influence on tumour growth.
    Winterfeld G; Hauff P; Görlich M; Arnold W; Fichtner I; Staab HJ
    J Cancer Res Clin Oncol; 1992; 119(2):91-6. PubMed ID: 1429831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen but not other selective estrogen receptor modulators antagonizes estrogen actions on luteinizing hormone secretion while inducing gonadotropin-releasing hormone self-priming in the rat.
    Sánchez-Criado JE; Guelmes P; Bellido C; Gónzalez M; Hernández G; Aguilar R; Garrido-Gracia JC; Bello AR; Alonso R
    Neuroendocrinology; 2002 Oct; 76(4):203-13. PubMed ID: 12411737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of analogues of luteinizing hormone-releasing hormone for the treatment of cancer.
    Furr BJ; Nicholson RI
    J Reprod Fertil; 1982 Mar; 64(2):529-39. PubMed ID: 6461763
    [No Abstract]   [Full Text] [Related]  

  • 16. Morphology, growth characteristics and oestrogen-binding capacity of DMBA-induced mammary tumours from ovariectomized rats.
    Boylan ES; Fowler EH; Wittliff JL
    Br J Cancer; 1977 May; 35(5):602-9. PubMed ID: 405032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumour potential of a new luteinizing hormone releasing hormone analogue, ICI 118630.
    Nicholson RI; Walker KJ; Maynard PV
    Eur J Cancer (1965); 1980; Suppl 1():295-9. PubMed ID: 6459236
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential use of analogs of luteinizing hormone-releasing hormones in the treatment of hormone-sensitive neoplasms.
    Schally AV; Redding TW; Comaru-Schally AM
    Cancer Treat Rep; 1984 Jan; 68(1):281-9. PubMed ID: 6362868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumour activity of folligen, a novel gonadotropin-releasing hormone analogue against DMBA-induced tumours in the rat.
    Nicholson RI; Kéri G
    Tumour Biol; 1992; 13(1-2):44-50. PubMed ID: 1534181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine-dependent rat mammary tumor regression: use of a gonadotropin releasing hormone analog.
    Johnson ES; Seely JH; White WF; DeSombre ER
    Science; 1976 Oct; 194(4262):329-30. PubMed ID: 823643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.